REGISTERED NUMBER: 07827001 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2025

FOR

WCC PHARMA LIMITED

Page

Company Information

1

Balance Sheet

2

to

3

Notes to the Financial Statements

4

to

9

DIRECTOR:

I A Onuchukwu

REGISTERED OFFICE:

21 Storey Street

Hull

E Yorkshire

HU1 3SA

REGISTERED NUMBER:

07827001 (England and Wales)

ACCOUNTANTS:

Majors Limited

57 Spyvee Street

Hull

E. Yorks

HU8 7JJ

FIXED ASSETS

Intangible assets

4

773,246

827,190

Tangible assets

5

1,148,359

974,793

1,921,605

1,801,983

CURRENT ASSETS

Stocks

34,883

174,804

Debtors

6

535,926

664,312

Cash at bank

2,999

97,279

573,808

936,395

CREDITORS

Amounts falling due within one year

7

1,010,155

775,349

NET CURRENT (LIABILITIES)/ASSETS

(436,347

)

161,046

TOTAL ASSETS LESS CURRENT LIABILITIES

1,485,258

1,963,029

CREDITORS

Amounts falling due after more than one year

8

(695,499

)

(802,907

)

PROVISIONS FOR LIABILITIES

(129,959

)

(129,959

)

NET ASSETS

659,800

1,030,163

CAPITAL AND RESERVES

Called up share capital

40

40

Revaluation reserve

10

400,000

400,000

Retained earnings

259,760

630,123

SHAREHOLDERS' FUNDS

659,800

1,030,163

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 May 2026 and were signed by:

I A Onuchukwu - Director

1.	STATUTORY INFORMATION

WCC Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Development costs are being amortised evenly over their estimated useful life of nil years.

Intangible assets

The cost of the company's website has been capitalised and is being amortised over four years on a straight line basis.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Improvements to property

-

25% on cost

Plant and machinery

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 (2024 - 29 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

Goodwill

assets

Totals

£

£

£

COST

At 1 June 2024

and 31 May 2025

539,440

290,448

829,888

AMORTISATION

At 1 June 2024

-

2,698

2,698

Charge for year

53,944

-

53,944

At 31 May 2025

53,944

2,698

56,642

NET BOOK VALUE

At 31 May 2025

485,496

287,750

773,246

At 31 May 2024

539,440

287,750

827,190

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST OR VALUATION

At 1 June 2024

825,000

405,294

1,230,294

Additions

200,000

-

200,000

At 31 May 2025

1,025,000

405,294

1,430,294

DEPRECIATION

At 1 June 2024

-

255,501

255,501

Charge for year

-

26,434

26,434

At 31 May 2025

-

281,935

281,935

NET BOOK VALUE

At 31 May 2025

1,025,000

123,359

1,148,359

At 31 May 2024

825,000

149,793

974,793

Cost or valuation at 31 May 2025 is represented by:

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

Valuation in 2023

500,000

-

500,000

Cost

525,000

405,294

930,294

1,025,000

405,294

1,430,294

Fixed assets, included in the above, which are held under hire purchase contracts or finance leases are as follows:

Plant and

machinery

etc

£

COST OR VALUATION

At 1 June 2024

and 31 May 2025

12,600

DEPRECIATION

At 1 June 2024

and 31 May 2025

12,600

NET BOOK VALUE

At 31 May 2025

-

At 31 May 2024

-

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

236,147

146,695

Directors' current accounts

105,855

84,013

VAT

35,600

74,765

Prepayments and accrued income

158,324

358,839

535,926

664,312

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

122,952

100,000

Trade creditors

41,343

211,278

Tax

82,638

82,638

Social security and other taxes

197,780

120,447

Associated company

66,082

178,004

Other creditors

491,360

74,982

Accruals and deferred income

8,000

8,000

1,010,155

775,349

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans - 1-2 years

100,000

100,000

Bank loans - 2-5 years

595,499

702,907

695,499

802,907

9.	SECURED DEBTS

The following secured debts are included within creditors:

2025

2024

£

£

Bank loans

795,499

902,907

The bank loan is secured with a fixed and floating charge over the assets of the company.

10.

RESERVES

Revaluation

reserve

£

At 1 June 2024

and 31 May 2025

400,000

11.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 May 2025 and 31 May 2024:

2025

2024

£

£

I A Onuchukwu

Balance outstanding at start of year

84,013

103,605

Amounts advanced

58,490

29,978

Amounts repaid

(36,648

)

(49,570

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

105,855

84,013